17/04/2026 07:49 (UTC)
Barcelona, Spain, Apr 17 (EFE).- The Vall d’Hebron Institute of Oncology (VHIO) has launched a clinical trial of an advanced CAR-T therapy, which involves genetically modifying cells to attack cancer and will be tested on patients with certain solid tumors.FOOTAGE OF THE VHIO LABORATORY IN BARCELONA, SPAIN.
Product Suggestions